S H Kelkar & Company Ltd

- No explicit mention of any current or planned new fundraising through debt or equity was made in the call. - The company discussed debt levels, mentioning a gross debt of Rs. 583 crore as of Q1 FY24, which increased due to higher sales and working capital needs. - The management indicated plans to reduce debt over the coming years through free cash flow generated from operations, but also noted increased working capital requirements due to aggressive growth plans. - There is no indication of raising new equity capital; the focus seems to be on internal cash flow management and working capital optimization. - In summary, the company aims to manage debt through operational cash flow without announcing any new fundraising at this time.

- Indonesia plant CAPEX: US $4 million to $5 million (already communicated last year, to be operational soon). - Upgradation investments for Flavour and Nutrition facilities: Relatively small, about Rs. 14-15 crore in total for all plants. - Backward integration in Global Ingredients: No large CAPEX by the company; it's done mainly at the vendor's end through a tolling model; only minor CAPEX for storages and related infrastructure. - Plans to upgrade nutrition and baby care plants to meet global standards underway to enable catering to larger global customers. - Capacity utilization improvements: Europe operations targeting over 85% utilization; Indian subsidiary has capacity headroom (~45% utilization), to support growth without major expansions. - No current expansion planned in the European subsidiary; future growth leveraging capacities in India and Indonesia.

- Overall revenue growth guidance is double-digit, targeting 12% to 15% CAGR, with potential for higher double-digit growth if markets grow well. - Flavours division expects underlying CAGR of 12% to 14% for the full year. - Fragrance business is expected to grow at around 9% to 10% topline and 12%+ bottom-line growth in Europe and India. - Volume growth: Fragrance volumes grew 6% QoQ; Flavour volumes flat overall but growing in India. - New product development drives Rs. 50-70 crore new business annually. - Approximately 15% growth in Flavours is expected largely from new businesses. - Growth in India business expected to be double-digit, reflecting macroeconomic conditions. - Expansion in global markets through local manufacturing (e.g., Indonesia plant) will support growth and client engagement. - The pipeline of new projects is in place and working well.

- The company expects double-digit top-line growth going forward, with India business growing in double digits and Europe and India fragrance businesses aiming for 12%+ bottom-line growth. - EBITDA margin improvement is anticipated, with target levels above 16%, supported by better pricing strategy and stable raw material costs. - Global Ingredient business, currently negative EBITDA, is expected to reach around +10% EBITDA post full backward integration by Q4 FY24. - Volume growth: Fragrance volume grew 6% QoQ; Flavours showed flat volume growth overall but with India volumes up and exports fluctuating seasonally. - The collaboration with a large global FMCG partner through an RFP has potential to generate Rs.100 crore annual revenue eventually, although timelines remain fluid due to delays. - The company is reviewing its 3-5 year plan but aims for mid-to-high double-digit growth in formulations/new markets, targeting around 20% CAGR in overall revenue over 3 to 5 years.

- The company is engaged in an RFQ (Request for Quotation) process with a large global FMCG player. - The RFQ's expected annual commercial revenue is around Rs. 100 crore. - The total bid value for this RFQ is approximately Rs. 700-800 crore (7-8 times the Rs. 100 crore annual revenue). - The company expects to secure about one-eighth to one-tenth of this total bid value. - Commercial orders from this RFQ are expected to start coming from Q4 FY24 or Q1 FY25. - Some trial commercializations may occur in Q3 FY24. - The timeline is fluid, affected by client-side delays and testing phases. - No new RFQs mentioned beyond this; ongoing work continues to reflect expenses in the current quarters.